The economic impact of COVID-19: a comparative cost analysis of ICU hospitalizations before and during the pandemic

Read full text
Authors: Heloisa Helena Piva, Anna Miethke-Morais, Alex Jones Flores Cassenote, Luiz Augusto Carneiro-D´Albuquerque, Luciana Bertocco de Paiva Haddad
Cited by: 1
References: 23

Abstract

BACKGROUND: The COVID-19 economic impact on health institutions has been discussed since the beginning of the pandemic, and the repercussions in different spheres were enormous. The economic evaluation in health became necessary as a management tool. OBJECTIVE: To describe and compare the hospitalization costs in Intensive Care Units (ICUs) and the patients' clinical and demographic variables, before and during the COVID-19 pandemic. DATA SOURCES AND STUDY SETTING: Partial economic evaluation of patients admitted to four ICUs, in a Brazilian reference center, in two periods: pre-pandemic (03/30/19 ‒ 06/30/19) and pandemic (03/30/20 ‒ 06/30/20). STUDY DESIGN: Observational cohort study. DATA COLLECTION/EXTRACTION METHODS: Micro and macro costing methodology; clinical and demographic variables were considered for the comparative analysis. RESULTS: In 2019, 521 hospitalizations were analyzed. Patients were predominantly male (61%), between 31- and 60-years old (48.2%) and of white race (75.4%). In 2020, 610 hospitalizations were analyzed: 60.3% male, 51.6% > 60-years old and 65.2% white race. All ICUs had an increase in deaths (2019: average of 26.9%; 2020: average of 48.8%). The average total hospitalization costs and the average patient-day cost in 2019 was US$ 6051.01 and US$ 787.48, respectively; in 2020, US$ 19,492.73 and US$ 1542.74. Human resources was the component with the highest cost (2019: 51.6%; 2020: 78.2%). Patients who require additional therapeutic procedures had a higher average cost in 2020. CONCLUSION: During COVID, patients were older (> 60-years), a higher percentage of patients identified as mixed race, the death rate was significantly higher, and the length of stay was significantly higher, resulting in the outcome "discharge". The COVID cost was significantly higher. The main cost component was human resources, mainly during the COVID pandemic. Additional therapeutic procedures were associated with higher costs.

Fields of Study & Subjects

COVID-19 and healthcare impacts COVID-19 Clinical Research Studies Sepsis Diagnosis and Treatment

Publication details

Journal / source
Clinics
Publisher
Elsevier BV
Volume
81
Pages
100891–100891
Publication date
1 January 2026
Language
EN